Takei, Yoshio, and Takamasa Tsuchida. Role of the renin-angiotensin system in drinking of seawater-adapted eels Anguilla japonica: a reevaluation. Am J Physiol Regulatory Integrative Comp Physiol 279: R1105-R1111, 2000.-The role of ANG II, a potent dipsogenic hormone, in copious drinking of seawater eels was examined. SQ-14225 (SQ), an angiotensin-converting enzyme inhibitor, infused intra-arterially at 0.01-1 g ⅐ kg Ϫ1 ⅐ min Ϫ1 , depressed drinking and arterial blood pressure in a dose-dependent manner. The inhibition was accompanied by a small decrease in plasma ANG II concentration, which became significant at 1 g ⅐ kg Ϫ1 ⅐ min Ϫ1 . After the infusate was changed back to the vehicle, the depression of drinking and arterial pressure continued for Ͼ2 h, although plasma ANG II concentration rebounded above the level before SQ infusion. By contrast, infusion of anti-ANG II serum (0.01-1 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ) did not suppress drinking and arterial pressure, although plasma ANG II concentration decreased to undetectable levels. Plasma atrial natriuretic peptide and plasma osmolality, which influence drinking rate in eels, did not change during SQ or antiserum infusions. These results suggest that the renin-angiotensin system plays only a minor role in the vigorous drinking observed in seawater eels. The results also suggest that the antidipsogenic and vasodepressor effects of SQ in seawater eels are not due solely to the inhibition of ANG II formation in plasma.
BECAUSE ORAL INTAKE is the sole means to ingest water from the environment for seawater teleosts, they vigorously drink seawater to compensate for water lost osmotically across the body surfaces (17, 23, 25, 40) . Ingested seawater is desalted and diluted to isotonicity in the anterior gut and, finally, absorbed by the posterior gut together with Na ϩ and Cl Ϫ (19, 24, 27) . In fact, if drunk water is drained through an esophageal fistula, eels transferred to seawater suffered from gradual hypovolemia and hypernatremia and, finally, die 5 days after transfer (43) . Accordingly, it is obvious that drinking is essential for teleost fish to survive in seawater.
It is generally accepted that thirst in terrestrial mammals, birds, and reptiles is induced principally by three major stimuli: an increase in plasma osmolality (cellular dehydration), a decrease in blood volume (extracellular dehydration), and an increase in plasma ANG II (11) . By contrast, atrial natriuretic peptide (ANP) is recognized as a sole antidipsogenic hormone (29) . In teleost fish, however, extracellular dehydration and ANG II are potent dipsogenic stimuli (7, 17, 40) , but cellular dehydration caused by injections of hypertonic solutions is strongly antidipsogenic in the eel (42) . Because fish drink immediately after exposure to seawater in response to Cl Ϫ in the media (17) , drinking is ensured without increases in plasma osmolality. Recently, ANP was found to be a highly potent antidipsogen in the eel (46) .
It is uncertain which of the dipsogenic stimuli are involved in copious drinking of seawater teleosts. Although plasma osmolality of seawater fish is generally higher than that of freshwater fish, a hyperosmotic stimulus (cellular dehydration) may play a minor role, inasmuch as it apparently inhibits drinking in the eel (42) . The involvement of a hypovolemic stimulus (extracellular dehydration) is also unlikely, since blood volume does not differ between seawater-and freshwater-adapted eels (32) . The most probable candidate is ANG II, because its plasma concentration or plasma renin activity is higher in seawater-adapted euryhaline fish than in freshwater fish (16, 38, 45) . However, there are conflicting data showing that plasma ANG II concentration and plasma renin activity do not differ between freshwater-and seawater-adapted eels (32, 33, 39, 46) , although they transiently increase after seawater transfer. Therefore, it remains undetermined whether ANG II is important for drinking of seawater fish.
Various types of angiotensin-converting enzyme (ACE) inhibitors have been widely used in mammals to evaluate the role of ANG II in hemodynamic and hydromineral regulation (10) . With respect to thirst regulation, however, the effects of ACE inhibitors are biphasic, with an inhibition or stimulation depending on the dose (2). In fish, large doses of ACE inhibitors resulted in the inhibition of drinking in seawater-but not in freshwater-adapted fish (1, 14, 28, 36, 45) . In goldfish, however, SQ-14225 caused dose-related inhi-bition or stimulation of drinking (34) . Furthermore, SQ-20881 failed to inhibit drinking in some marine fish, although it was effective in inhibiting vasopressor action of ANG I (3). Therefore, the ACE inhibitors should be used with caution.
The aim of the present study is twofold. The first is to evaluate the role of the endogenous renin-angiotensin system in copious drinking of seawater eels. To this end, plasma ANG II concentration was depressed by two different mechanisms: slow infusion of an ACE inhibitor to inhibit ANG II formation and anti-ANG II serum to neutralize free ANG II in plasma. The antiserum was used instead of competitive ANG II receptor antagonists, since the latter are without effect in the eel (31) . The second is to determine whether the potent antidipsogenic effect of ANP observed in seawater eels is mediated by the accompanying depression of endogenous ANG II (46) , since ANG II is a potent dipsogen in eels (47) . Plasma ANP concentrations, arterial pressure, and plasma osmolality were monitored throughout the infusion, since these factors are shown to affect drinking in eels (18, 42, 46) .
MATERIALS AND METHODS
Animals. Cultured Japanese eels, Anguilla japonica, were purchased from a local dealer. They were kept in a 1-ton freshwater tank for a few days and then transferred to a 0.5-ton seawater tank and acclimated there for Ͼ2 wk before use. Seawater from the Pacific Ocean was purchased from Tokai Kisen (Tokyo, Japan). The Cl Ϫ concentration in the tank was checked regularly. Water in the tank was continuously filtered, aerated, and thermoregulated at 18 Ϯ 0.5°C. Eels were not fed after purchase. They weighed 192.4 Ϯ 2.9 (SE) g (n ϭ 17) at the time of the experiment. Animal care and protocols for animal experiments were performed according to the guidelines established by the Graduate School of Science, The University of Tokyo.
Surgical procedures. Eels were anesthetized in 0.1% (wt/ vol) tricaine methanesulfonate (Sigma Chemical, St. Louis, MO) in seawater neutralized with sodium bicarbonate for 10 min. Vinyl tubes (1.5 mm OD) were inserted into the esophagus and stomach, as described previously (39) . The esophageal catheter was used for measurement of drinking rate and the stomach catheter for reintroduction of drunk water. In addition, polyethylene tubes (0.8 mm OD) were inserted into the dorsal aorta and ventral aorta, the former being used for drug infusion and blood pressure measurement and the latter for blood sampling. The eels that bled Ͼ0.05 ml (0.7% of total blood volume) during surgery were excluded from the experiment because of accelerated drinking rate in these fish.
After surgery the esophageal catheter was connected to a drop counter and the stomach catheter to a pulse injector synchronized with the drop counter (43) . Eighty percent seawater was reintroduced into the stomach, because the seawater that appeared from the esophageal catheter was diluted to this concentration by desalting during passage through the esophagus (19, 24) . The catheters in the aorta were connected to plastic syringes filled with 0.9% NaCl solution. The catheter in the dorsal aorta was connected via a three-way stopcock to a 1-ml syringe for drug infusion and to a pressure transducer (model DX-300, Nihon Kohden, Tokyo, Japan). The transducer was connected to a polygraph (366 system, NEC-San-ei, Tokyo, Japan) and a pen recorder for continuous measurement of arterial pressure. Eels were allowed to recover from anesthesia for Ͼ18 h postoperatively.
Experimental protocol. Initially, various ANG II receptor antagonists, such as saralasin, losartan (CV-11974), and CGP-42112, were tested in terms of the vasopressor effect. However, none was an effective blocker in the eel, as in other nonmammalian species (20, 30, 44) , except losartan in the trout (8) . Therefore, an ACE inhibitor and an anti-ANG II serum were used to block the ANG II effect. Eels were divided into two groups: one received SQ-14225 infusions (n ϭ 8), and the other received anti-ANG II serum infusions (n ϭ 6). The anti-ANG II serum was raised against mammalian ANG II and cross-reacted 100% with eel ANG II (46) . The infusion was initiated with a vehicle (0.9% NaCl containing 0.01% Triton X-100) for 1 h and then with increasing doses of SQ-14225 (0.01, 0.1, and 1 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ) or antiserum (0.01, 0.1, and 1 l ⅐ kg Ϫ1 ⅐ min Ϫ1 ) for 30 min at each dose and ended with a vehicle infusion for Ͼ2 h. Normal rabbit serum was also infused on the same time schedule in three different eels, which served as controls for antiserum infusion. Infusion rate was 0.3 ml/30 min, whereas 0.6 ml of blood was sampled every 30 min into the chilled syringe containing 10% 2K-EDTA (10 l/ml blood). After centrifugation, plasma was saved while blood cells were injected into the circulation with 0.3 ml of saline in 5 min to avoid changes in blood volume. Before injection, blood cells were washed twice with 1 ml of saline to remove EDTA.
The plasma parameters measured were Na ϩ , ANP, and ANG II concentrations and osmolality. Plasma Na ϩ concentration was determined with an atomic absorption spectrophotometer (model Z5300, Hitachi, Tokyo, Japan) and plasma osmolality with a vapor pressure osmometer (model 5500, Wescor). Plasma ANG II and ANP concentrations were measured by homologous RIA with 50 l of plasma (22, 46) . The intra-and interassay coefficients of variation were 5.2 and 12.6% for ANG II and 5.1 and 11.5% for ANP, respectively. After infusion of anti-ANG II serum or normal rabbit serum, protein A-Sepharose CL-4B (3 mg/100 l; Pharmacia Biotech, Uppsala, Sweden) was added to 100 l of plasma, and the mixture was incubated for 50 min at 4°C with gentle shaking. The incubate was then centrifuged at 24,000 g for 20 min at 4°C to remove IgG-coupled ANG II. The supernatant was lyophilized, reconstituted in 100 l of water, and used for measurement of ANG II by RIA. All determinations were made in duplicate or triplicate.
Analysis of data. The time-course data were analyzed statistically by ANOVA followed by Tukey's test at each time point. Significance was determined at P Ͻ 0.05. Values are means Ϯ SE.
RESULTS
Effects of SQ-14225 on drinking, plasma ANG II, and blood pressure. Infusion of SQ-14225 (0.01-1 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ) inhibited drinking in seawater eels in a dose-dependent manner (Fig. 1) ; the intake at 1 g was as low as the level of freshwater fish (47) . The water intake recovered after infusate was changed from SQ-14225 to saline, but it was still significantly lower than the normal intake of seawater fish even after 2 h. Plasma ANG II concentration also appeared to decrease dose dependently during SQ-14225 infusion (Fig. 1B) . However, the decrease was significant only at the highest dose. Plasma ANG II concentration rebounded above the normal level for 2 h after SQ-14225 was replaced by saline, although drinking was still significantly inhibited during the period. Changes in arterial pressure were similar to changes in drinking rate: a profound decrease during SQ-14225 infusion followed by a small recovery after its termination (Fig. 1C) . The hypotension continued for Ͼ2 h after termination of SQ-14225 infusion, despite an increase in plasma ANG II.
Effects of anti-ANG II serum on drinking, plasma ANG II, and blood pressure. Infusion of anti-ANG II serum (0.01-1 l ⅐ kg Ϫ1 ⅐ min Ϫ1 ) caused only slight, nonsignificant decreases in drinking rate ( Fig. 2A) . By contrast, plasma ANG II concentration profoundly decreased during antiserum infusion, and it fell to undetectable levels (Ͻ0.3 fmol/ml) at 1 l ⅐ kg Ϫ1 ⅐ min Ϫ1 (Fig.  2B) . The low levels continued for Ͼ2 h after termination of antiserum infusion. Arterial blood pressure did not change during antiserum infusion, despite profound decreases in plasma ANG II concentration (Fig.  2C) . No changes were observed in drinking rate, plasma ANG II concentration, and blood pressure during infusion of normal rabbit serum (data not shown).
Changes in plasma ANP, Na ϩ , and osmolality. Plasma ANP concentration did not show consistent changes during infusion of SQ-14225 and anti-ANG II serum (Fig. 3, A and D) . Changes in plasma Na ϩ concentration (Fig. 3, B and E) and plasma osmolality (Fig. 3, C and F) were also unchanged during SQ-14225 or antiserum infusion. The infusion of normal rabbit serum did not change these parameters (data not shown).
DISCUSSION
Role of ANG II in drinking of seawater fish. Teleost fishes are known to drink copiously in seawater to compensate for water lost osmotically across the body surfaces (23) . Among major dipsogenic stimuli identified to date, i.e., osmotic stimulus, volemic stimulus, and ANG II (11), the osmotic stimulus may play a significant role in seawater drinking, because plasma osmolality is invariably higher in seawater fish than in freshwater fish. However, fish possess a mechanism to start drinking in response to osmolytes in external media without changes in plasma osmolality (17) . Furthermore, an acute increase in plasma osmolality by bolus injections of hypertonic solutions inhibited drinking in eels (42) , although the same procedure potently induces drinking in tetrapods (11, 40) .
In contrast to the osmotic stimulus, the hypovolemic stimulus was potently dipsogenic in eels (17) , and blood Fig. 2 . Changes in drinking rate, plasma ANG II concentration, and arterial blood pressure after infusion of anti-ANG II serum in seawater eels (n ϭ 6). Antiserum was diluted with 0.9% NaCl, and each volume was infused in 0.3 ml as indicated on the abscissa. * P Ͻ 0.05 compared with initial vehicle infusion. volume decreased transiently after transfer of freshwater fish to seawater (25) . However, blood volume gradually returns to normal and fish become normovolemic after seawater adaptation (32). Among three major dipsogenic stimuli identified in mammals, therefore, ANG II appears to be the most probable candidate responsible for drinking of seawater-adapted fish.
It has been reported that plasma renin activity or ANG II concentration was higher in the seawateradapted eel Anguilla anguilla than in freshwater eels (16, 45) . In another eel species, A. japonica, plasma ANG II concentration increased transiently after transfer to seawater (33) . However, it decreases gradually during the course of seawater adaptation, so that plasma renin activity and ANG II concentration do not differ between freshwater-and seawater-adapted eels (33, 39, 46) . Although a possibility still remains that the dipsogenic receptors for ANG II are sensitized after adaptation to seawater, it is obvious that ANG II is not increased in seawater-adapted A. japonica. In the present study, drinking was not inhibited in seawater eels, even though plasma ANG II concentration was decreased to undetectable levels by infusion of anti-ANG II serum. At least in A. japonica, therefore, the role of circulating ANG II in drinking of seawater fish is not significant.
In contrast to anti-ANG II serum, inhibition of ACE by SQ-14225 profoundly inhibited drinking and lowered arterial pressure in seawater eels in this study. Similar results have previously been reported in A. anguilla (33, 45) and in other euryhaline fishes (1, 14, 28) by bolus injections of ACE inhibitors into seawateradapted fish. These results seem to indicate that the renin-angiotensin system plays an important role in maintenance of drinking and arterial pressure in seawater fishes. However, the effect of ACE inhibitors should be interpreted with caution because of their nonspecific inhibition of other proteases (10) .
Effects of SQ-14225 are not due to inhibition of ANG II formation. Although removal of plasma ANG II by anti-ANG II serum did not inhibit drinking, its slight decrease caused by SQ-14225 inhibited drinking profoundly. Furthermore, the inhibition of drinking by SQ-14225 continued after termination of infusion, even though plasma ANG II concentration rebounded above normal. Therefore, it is obvious that the antidipsogenic effect of SQ-14225 is not caused by inhibition of ANG II formation in plasma. The increase in plasma ANG II after SQ-14225 infusion may be due to the sudden conversion of accumulated ANG I to ANG II and to the activation of plasma renin activity by SQ-14225, as reported in other species (26) . Changes in arterial Fig. 3 . Changes in plasma atrial natriuretic peptide (ANP) concentration, plasma Na ϩ concentration, and plasma osmolality after infusion of SQ-14224 (n ϭ 8) or anti-ANG II serum (n ϭ 6) in seawater eels. pressure followed a time course similar to that of drinking. Therefore, the hypotension caused by SQ-14225 also is not due to the inhibition of peripheral ANG II formation. It is well known that SQ-14225 is a relatively nonspecific carboxyl dipeptidase inhibitor that blocks a variety of proteases other than ACE (4). Furthermore, ACE itself is involved in the metabolism of various biologically active peptides, including bradykinin, substance P, neurokinins, neurotensin, and opioids, some of which may affect drinking (9) . Accordingly, the SQ-14225 effects cannot simply be ascribed to the inhibition of the renin-angiotensin system.
The dose of SQ-14225 used in the present study (0.01-1 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ) seems to be extremely low compared with those used in other fish studies. SQ-14225 inhibited drinking of seawater in A. anguilla at 72 mg/kg of intramuscular (36) or intravenous (45) injection. Similar inhibition was reported in A. japonica at 5 mg/kg of SQ-14225 (33) and in juvenile Atlantic salmon at 50 mg/kg of enalapril (14) after intraperitoneal injections. High doses of SQ-14225 were required probably because of bolus injections, since chronic oral administration of perindopril, another ACE inhibitor, at 1.
) suppressed plasma ANG II concentration in the rat (5).
In the goldfish, which normally drinks little, 0.1-1 mg/kg of intraperitoneal SQ-14225 stimulated drinking but 10-50 mg/kg was without effect (34) . Similar dose-related effects of SQ-14225 have been reported in the rat, where low doses of SQ-14225 enhanced drinking, whereas high doses were generally inhibitory (12) . It is assumed that low doses of SQ-14225 inhibit only peripheral ACE (37) , and increased plasma ANG I is converted to ANG II in the brain to stimulate drinking. At high doses, however, SQ-14225 may inhibit peripheral and brain ACE to suppress drinking. In the present study, low doses of SQ-14225 inhibited drinking, but it is not known whether SQ-14225 penetrated the eel brain to inhibit brain ACE. The presence of ACE in eel brain has not been examined.
Antidipsogenic effect of ANP is not mediated by decreased plasma ANG II. ANP infusion at physiological doses inhibited drinking with a concomitant decrease in plasma ANG II concentration in seawater eels (46) . Because ANG II is highly dipsogenic in the eel (47) , there is a possibility that the antidipsogenic effect of ANP is mediated by suppression of plasma ANG II concentration. However, the present study showed that removal of ANG II from plasma with anti-ANG II serum did not inhibit drinking in seawater eels. Therefore, ANP may inhibit drinking directly by acting on the brain in the eel, as in the rat (29) . It has been suggested that ANG II acts on the brain, probably the medulla oblongata, of eels (40, 41) . Because eels are extremely sensitive to the antidipsogenic action of ANP compared with mammals (29, 46) , the eel may provide a good model to pursue the site of action of ANP in the brain.
Perspectives
The present study provides evidence to suggest that plasma ANG II is not responsible for drinking of seawater in A. japonica. Because ANG II and ANP are hormones that are secreted immediately after changes in external media and quickly disappear from the circulation, they may be important only at the transition from freshwater to seawater (21, 33) . A number of osmoregulatory hormones, such as cortisol, growth hormone, and prolactin (15) , have slow and long-lasting action. In fact, cortisol has been shown to regulate drinking in fish (14) . It is of interest to examine how ANG II and ANP affect the secretion of these longacting hormones to regulate long-term drinking in seawater fish.
An acute increase in plasma osmolality inhibits drinking in eels probably because of profound increases in plasma ANP concentration (21, 42) . Therefore, it is possible that the higher plasma osmolality of seawateradapted eels is the cause of their continuous drinking, since their plasma ANP level does not differ from that of freshwater eels (22) . It is reported that slow infusion of hypertonic saline increased drinking rate in freshwater eels (17) .
It is evident that inhibition of drinking by SQ-14225 is not due to inhibition of the peripheral renin-angiotensin system. However, there is a possibility that SQ-14225 inhibits brain ACE to inhibit local ANG II formation, although there is no evidence for the presence of a brain renin-angiotensin system in the eel. Furthermore, if ANG II acts on the circumventricular structures that lack a blood-brain barrier in the eel, as in mammals and birds (11) , even anti-ANG II serum with high molecular mass may block the ANG II effect in the brain. Therefore, it is important to determine the site of action of ANG II and the presence of an intrinsic renin-angiotensin system in the eel brain to pursue this issue.
Finally, what is the cause of profound inhibition of drinking after SQ-14225 infusion? In addition to conversion of ANG I to ANG II, ACE is importantly involved in degradation of bradykinin to inactive metabolites, which gives rise to the name kininase II. Therefore, it is possible that the antidipsogenic and vasodepressor effects of SQ-14225 are mediated by activation of the kallikrein-kinin system. Bradykinin is vasodepressor (6) and dipsogenic (13) in mammals. However, bradykinin causes a triphasic effect on blood pressure in the trout (35) . Very recently, we found that an infusion of eel bradykinin into seawater eels potently inhibited drinking (unpublished data). Thus bradykinin could be a mediator of the antidipsogenic action of SQ-14225 in seawater eels.
